George Yancopoulos - Jun 21, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**George D. Yancopoulos
Stock symbol
REGN
Transactions as of
Jun 21, 2021
Transactions value $
-$43,112,141
Form type
4
Date filed
6/23/2021, 04:02 PM
Next filing
Aug 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 +82.1K $0.00 82.1K Jan 12, 2021 By Trust for Chldn. F1
transaction REGN Common Stock Sale -$393K -738 -0.9% $532.89 81.4K Jun 21, 2021 By Trust for Chldn. F1, F2, F3
transaction REGN Common Stock Sale -$4M -7.49K -9.21% $533.66 73.9K Jun 21, 2021 By Trust for Chldn. F1, F2, F4
transaction REGN Common Stock Sale -$4.4M -8.24K -11.15% $534.48 65.6K Jun 21, 2021 By Trust for Chldn. F1, F2, F5
transaction REGN Common Stock Sale -$2.23M -4.15K -6.33% $535.63 61.5K Jun 21, 2021 By Trust for Chldn. F1, F2, F6
transaction REGN Common Stock Sale -$2.02M -3.77K -6.13% $536.37 57.7K Jun 21, 2021 By Trust for Chldn. F1, F2, F7
transaction REGN Common Stock Sale -$3.57M -6.64K -11.5% $537.61 51.1K Jun 21, 2021 By Trust for Chldn. F1, F2, F8
transaction REGN Common Stock Sale -$2.62M -4.87K -9.53% $538.54 46.2K Jun 21, 2021 By Trust for Chldn. F1, F2, F9
transaction REGN Common Stock Sale -$1.78M -3.31K -7.15% $539.66 42.9K Jun 21, 2021 By Trust for Chldn. F1, F2, F10
transaction REGN Common Stock Sale -$4.38M -8.1K -18.88% $540.61 34.8K Jun 21, 2021 By Trust for Chldn. F1, F2, F11
transaction REGN Common Stock Sale -$10.8M -19.9K -57.2% $541.44 14.9K Jun 21, 2021 By Trust for Chldn. F1, F2, F12
transaction REGN Common Stock Sale -$5.7M -10.5K -70.57% $542.43 4.38K Jun 21, 2021 By Trust for Chldn. F1, F2, F13
transaction REGN Common Stock Sale -$1.24M -2.28K -51.92% $543.13 2.11K Jun 21, 2021 By Trust for Chldn. F1, F2, F14
holding REGN Common Stock 987K Jun 21, 2021 Direct
holding REGN Common Stock 5.85K Jun 21, 2021 By 401(k) Plan
holding REGN Common Stock 212K Jun 21, 2021 by 2019 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Class A Stock Gift $0 +14K $0.00 14K Apr 15, 2021 Common Stock 14K By Tr. for Daughter F15, F16, F17
transaction REGN Class A Stock Gift $0 -14K -100% $0.00* 0 Apr 15, 2021 Common Stock 14K by Daughter F15, F16, F18
transaction REGN Class A Stock Gift $0 -5.38K -100% $0.00* 0 Apr 15, 2021 Common Stock 5.38K by Son F15, F16, F18
transaction REGN Class A Stock Gift $0 +5.38K $0.00 5.38K Apr 15, 2021 Common Stock 5.38K by Trust for Son F15, F16, F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As investment trustee of trusts for the benefit of the reporting person's children.
F2 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F3 Represents volume-weighted average price of sales of 738 shares of Company stock on June 21, 2021 at prices ranging from $532.56 to $532.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 7,494 shares of Company stock on June 21, 2021 at prices ranging from $533.14 to $533.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 8,236 shares of Company stock on June 21, 2021 at prices ranging from $534.01 to $534.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 4,154 shares of Company stock on June 21, 2021 at prices ranging from $535.05 to $535.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 3,768 shares of Company stock on June 21, 2021 at prices ranging from $536.02 to $536.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 6,636 shares of Company stock on June 21, 2021 at prices ranging from $537.05 to $537.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 4,868 shares of Company stock on June 21, 2021 at prices ranging from $538.01 to $538.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F10 Represents volume-weighted average price of sales of 3,306 shares of Company stock on June 21, 2021 at prices ranging from $539.14 to $539.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F11 Represents volume-weighted average price of sales of 8,099 shares of Company stock on June 21, 2021 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F12 Represents volume-weighted average price of sales of 19,911 shares of Company stock on June 21, 2021 at prices ranging from $541.00 to $541.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F13 Represents volume-weighted average price of sales of 10,514 shares of Company stock on June 21, 2021 at prices ranging from $542.00 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F14 Represents volume-weighted average price of sales of 2,276 shares of Company stock on June 21, 2021 at prices ranging from $543.01 to $543.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F15 Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.
F16 These shares of Class A Stock are presently convertible and such conversion feature does not expire.
F17 These shares of Class A Stock are held in a trust for the benefit of the reporting person's child, of which the reporting person is trustee.
F18 These shares of Class A Stock were held in custody for the benefit of the reporting person's child.